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SUMMARY
A prospective study was designed to evaluate disorders of hemostasis and levels of anticardiolipin antibodies (ACL) in 30 patients
with severe leptospirosis and acute renal failure (ARF) (ARF was defined as serum creatinine  1.5 mg/dL). The patients had been
admitted to the Walter Cantídio University Hospital, São José Infectious Diseases Hospital and General Hospital of Fortaleza, Ceará,
from August 1999 to July 2001. They all were male, with a mean age of 32 ± 14 years and with clinical and laboratory diagnoses of
ARF leptospirosis. The time elapsed between onset of symptoms and the first hemorrhagic manifestation was 9 ± 4 days. Bleeding
was observed in 86% of the patients. Laboratory tests showed significantly high levels of urea (181 ± 95 mg/dl), fibrinogen, (515 ±
220 mg/dl), prothrombin time (13.3 ± 0.9 seconds) and low platelet counts (69 ± 65x103/mm3) on admission. There was no elevation
in activated partial thromboplastin time or thrombin time. Levels of IgM and IgG ACL concentrations were significantly increased (p
< 0.05) in leptospirosis patients when compared to control patients (28.5 ± 32.4 vs. 11.5 ± 7.9MPL U/ml and 36.7 ± 36.1 vs. 6.5 ± 2.5
GPL U/ml), respectively. Vasculitis, thrombocytopenia and uremia should be considered important factors for the pathogenesis of
hemorrhagic disturbances and the main cause of death in severe leptospirosis.
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INTRODUCTION
Leptospirosis is a zoonosis caused by microorganisms of the genus
Leptospira, which has a worldwide distribution. The Leptospira
interrogans complex, of pathogenic nature, contains 23 serogroups and
approximately 200 serovars. The disease affects humans, as well as wild
and domestic animals, thus constituting one of the most important
zoonoses of our environment. In man, pathogenic leptospira can
determine various clinical manifestations, from “silent” infections to
the icterohemorrhagic form that is also known as Weil’s syndrome, which
is characterized by the presence of jaundice, followed by a tendency
toward hemorrhagic disturbances and acute renal failure (ARF).
The hemorrhagic phenomena present in our environment have been
described by several authors2,3,15,19-24. PEREIRA DA SILVA et al.24 have
described hemorrhagic manifestations in 95% of cases of severe clinical
forms of leptospirosis. The following symptoms were reported in the above
study, according to decreasing order of frequency: petechiae, epistaxis,
hemoptoic expectoration, macroscopic hematuria, ecchymoses, hematemesis,
melena, hemoptysis, and bleeding through venous dissection sites. LOMAR
et al.16, while studying 19 cases of leptospirosis, concluded that pulmonary
hemorrhage had been the main cause of death in 15 cases and that massive
gastrointestinal bleeding had been the cause in three cases.
JAROONVESAMA et al.14, EDWARDS et al.8 and NICODEMO et
al.22 have described, in case studies of leptospirosis, alterations in
coagulation due to prolonged prothrombin, thrombin and partial
thromboplastin times. Low platelet counts, alterations in factor V,
alterations in fibrinogen degradation products and of fibrinogen levels
are also described.
Bleeding is a common complication in leptospirosis and has become
the main cause of death in this disease. Various systematic studies of the
alterations in hemostasis have been published7,8,14,19-25.
Spirochete-type bacteria, such as those in syphilis, can induce cross
reactivity with anticardiolipin antibodies (ACL)18. More recently, titers
of ACL have been described in patients with Lyme disease and with
leptospirosis, both illnesses are caused by spirochetes17. The antigenic
stimuli responsible for the induction of such antibodies in a spirochete
infection and their relationship to the complications of the disease are
still relatively unknown.
The ACL is an autoantibody that acts against phospholipids,
especially those with a negative charge, and is associated with a syndrome
characterized by recurring episodes of arteriovenous thrombosis,
thrombocytopenia and repeated miscarriages27. These antibodies were
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first described in association with cases of systemic lupus
erithematosus13,18. In the absence of neoplasms and drug use, the condition
is denoted as primary antiphospholipid syndrome. The physiopathology
of antiphospholipid syndrome is little known.
Thus, the proposal of this study is to evaluate those hemostatic factors
related to the hemorrhagic manifestations, as well as the nature and
average duration of the bleeding disturbances. The presence of ACL
titers in severe forms of leptospirosis will be also determined.
PATIENTS AND METHODS
Thirty patients with epidemiologic, clinical and laboratory diagnoses
of leptospirosis were studied prospectively. All of the patients were male,
with ages varying between 16 and 63 years (average of 32 ± 14 years).
They had severe forms of leptospirosis, with jaundice and acute renal
failure, defined as serum creatinine  1.5 mg/dL. The patients had been
admitted to the Walter Cantídio University Hospital of the Faculty of
Medicine of the Federal University of Ceará, the São José Hospital of
Infectious Diseases and the General Hospital of Fortaleza. They were
evaluated on admission, during hospital stay and discharge, thus
broaching the acute and convalescence phases of the disease. The study
lasted 23 months, from August 1999 to July 2001, with no limit being
set as to the number of patients to comprise the study population. Patients
that had any other diseases that caused hemorrhagic phenomena, such
as hemophilia, chronic liver disease, systemic lupus erythematosus,
leukemia, dengue fever, kala-azar, typhoid fever, scurvy, etc, were
excluded. All patients included in the study had positive microscopic
serum agglutination reactions for leptospirosis, with titers greater than
1:400.
Signs and symptoms such as fever, jaundice, myalgia, headaches,
vomiting, diarrhea, abdominal pain, reduction of urinary output and
dyspnea were registered. The presence and average duration of
hemorrhagic manifestations, such as hematemesis, hemoptysis, melena,
epistaxis, hemoptoic sputum, hematochezia, hemorrhage in dissection
sites, petechiae, ecchymoses, gingival bleeding and hematuria were also
recorded.
Three times a week serum levels of urea, creatinine, sodium,
potassium, bilirubin, platelets, aminotransferases (AST, ALT), total
proteins and fractions, lactate dehydrogenase (LDH), creatine kinase
(CK) and total blood cell counts were measured. On admission and
discharge the prothrombin time (PT) (reference values: 12.0-14.4
seconds), partial activated thromboplastin time (PATT) (reference values:
32.0-38.4 seconds), thrombin time (TT) (reference values: 9.8-11.0
seconds) and fibrinogen levels (reference values: 150-380 mg/dl) were
all measured.
During the immune phase, between the 9th and 12th days after onset
of symptoms, levels of anticardiolipin antibodies (ACL) were measured
by the ELISA kit method (MELISA anticardiolipin IgG and IgM, Walker
Diagnostics, Cambridge). Reference values for normal patients were <
10 GLP U/ml for IgG and < 7 MLP U/ml for IgM28. During hospital
stay, occurrence of dialysis, as well as the type performed (hemodialysis
or peritoneal dialysis), presence of hemorrhagic manifestations and
occurrence of death were also recorded.
Anticardiolipin antibody levels were analyzed in the sera of nine
patients with various infectious diseases except leptospirosis (control
group), during the acute phase of each disease. Five of the patients were
female and 4 were male, the average age being 35 ± 10 years. Two of the
patients had kala-azar, 2 had tetanus, 2 had septicemia caused by
Staphylococcus aureus, 1 had dengue fever, 1 had type A hepatitis, and
1 had meningococcemia. The diagnoses of all of these patients’ respective
diseases were confirmed through laboratory exams (serology, agent
isolation, etc.), with the exception of the patients with tetanus, which
diagnosis was made through the clinical history and physical examination.
All of the members of the control group were in-patients in the São José
Hospital of Infectious Diseases.
The study protocol was approved by the Ethics Committee of the
Walter Cantídio University Hospital, Faculty of Medicine, Federal
University of Ceará. All patients gave informed consent.
For statistical analysis of the results, the Student t test was used in
order to verify variations between laboratory values on admission versus
discharge and ACL titers of the patients with leptospirosis versus control
group. Results were expressed as mean ± SD and were considered
significant when descriptive levels were less than 5% or p < 0.05.
RESULTS
The main signs and symptoms upon admission excluding
hemorrhagic manifestations were fever, jaundice and myalgia in 100%
of the cases; vomiting, diarrhea, headaches, decreased urinary output
and abdominal pain in 30%; and dyspnea in 10%.
The duration of hospital stay was 12 ± 9 days, and the time elapsed
until occurrence of hemorrhagic manifestations was 9 ± 4 days after
onset of the clinical course. A total of 26 of the 30 patients (86%)
presented with some form of bleeding during hospital stay; of these, 17
(56%) exhibited more than one form of bleeding. The hemorrhagic
phenomena observed were: hemoptysis in 12 patients, conjunctival
bleeding in 9, macroscopic hematuria in 7, melena in 6, epistaxis in 6,
hematemesis in 6, petechiae in 3, gingival bleeding in 1, hematochezia
in 1 and bleeding from venous dissection sites in 1 patient.
There were a significant decline in hematocrit and hemoglobin levels
during hospital stay due to the hemorrhagic disturbances. Patient serum
levels of urea and creatinine upon admission were elevated, yet, by the
time of discharge, there had been a significant reduction (p < 0.05),
indicating recovery of renal function (Table 1). On admission, total
bilirubin levels were 23 ± 14 mg/dl, albumin levels were 2.4 ± 0.3 g/dl,
CK levels were 445 ± 690U /ml, LDH levels were 764 ± 334 U/ml, AST
levels were 135 ± 89 U/ml and ALT levels were 95 ± 73 U/ml.
Prothrombin time on admission was significantly prolonged and
fibrinogen levels were significantly elevated compared to those upon
discharge. PATT and TT during admission were unaltered compared to
discharge values (Table 1).
Platelet counts were fairly low on admission, but by the time of
discharge, they had returned to normal (Table1). Only two patients had
platelets levels that were above 150,000/mm³ at the time of admission
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and four patients presented with counts lower than 150,000/mm³ upon
discharge (with the exception of the 3 patients that had died).
Measurement of the IgM and IgG fractions of ACL levels in 28 of the
30 patients revealed that 18 patients (64.2%) had levels considered reactive
for the IgM fraction of this type of antibody, at 28.5 ± 32.4 MPL U/ml.
Twenty-two patients (78.5%) had reactive levels for the IgG fraction with
counts of 36.7 ± 36.1 GPL U/ml. Levels of ACL in the 9 patients of the
control group were 11.5 ± 7.9 MPL U/ml for the IgM fraction and 6.5 ±
2.5 GPL U/ml for the IgG fraction. ACL titers between the patients with
leptospirosis and those of the control group were significantly different (p
< 0.05) for both the IgM and IgG fractions (Fig. 1 and 2).
Regarding the need for dialysis, 19 (63%) patients underwent dialysis
due to onset of acute renal insufficiency that was non-responsive to
hydration. Of these, 13 underwent peritoneal dialysis and 6 had
continuous slow hemodialysis.
Three patients died. One patient developed massive pulmonary
hemorrhage, another suffered bleeding from various sites (hemoptysis,
hematemesis, and bleeding from a venous dissection site) and the third
developed a rapid decline in consciousness, with eventual coma and
anisocoria, suggesting central nervous system hemorrhage.
DISCUSSION
Analysis of the study population revealed that the group consisted
primarily of young adults, all of the male sex. The absolute participation
of male patients can be explained by examination of some patients’
occupations, as leptospirosis is a disease with an important
epidemiological-occupational component involved in its
transmission1,11,30. On the other hand, in our environment, this illness
has a global distribution that is independent of occupation, as all
patients had described the main transmitters (rats) as present in their
surroundings.
Table 1
Admission and discharge laboratory data of patients with leptospirosis
ADMISSION DISCHARGE p
n = 30 # n = 27
Hematocrit (%) 33 ± 5* 27 ± 6 0.0001
Hemoglobin (g/dl) 11 ± 2* 9 ± 2 0.007
Urea (mg/dl) 182 ± 95* 67 ± 31 0.0004
Creatinine (mg/dl) 5.7 ± 3.4* 1.6 ± 1.0 0.0009
Prothrombin Time (seconds) 13.3 ± 0.8* 12.8 ± 0.8 0.025
Activated Partial Thromboplastin  Time (seconds) 32.7 ± 2.1 33.1 ± 2.8 0.530
Thrombin Time (seconds) 11.0 ± 1.4 10.8 ± 1.5 0.110
Fibrinogen (mg/dl) 515 ± 220* 322 ± 95 < 0.0001
Platelets (x 103/mm3) 69 ± 65* 280 ± 181 < 0.0001
Significant *p < 0.05 versus discharge. # (n = 27) three patients died.
Fig. 2- IgG anticardiolipin antibody titers in leptospirosis and control. *p < 0.05 vs control.Fig. 1- IgM anticardiolipin antibody titers in leptospirosis and control. *p < 0.05 vs control.
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In the current study, the majority of patients with severe forms of
leptospirosis presented with some type of alteration in hemostasis with
subsequent hemorrhagic manifestations that occurred, on average, after
the first week of symptom onset; this period began on the ninth day and
corresponds to the beginning of the immunological phase of the disease.
The complication most frequently found was of pulmonary nature with
clinical manifestation in the form of hemoptysis, thus revealing the recent
presentation, in our midst, of pulmonary complaints associated with
severe forms of leptospirosis1,2,3,5,10.
Hemostasis consists of three main elements: coagulation factors,
platelets, and blood vessels. Typically, PT is altered when changes or
deficiencies are present in coagulation factors dependent on vitamin K,
such as factors II, VII and X, and in C and S proteins. In the present
study a statistically significant variation in PT upon admission was
observed compared to that upon discharge. The significant increase in
bilirubin level and slight elevation in transaminase level observed during
the acute phase suggest hepatic cholestasis that had led to a vitamin K
deficiency and to an eventual increase in prothrombin time4.
It is known that TT is influenced by three factors: decreased
fibrinogen levels, increase in fibrinogen/fibrin degradation products and
administration of heparin. In the present study, on average, TT did not
suffer elevation, which is corroborated by the fibrinogen levels found.
Deficiencies in the intrinsic factors of coagulation (factors VIIIc,
IX, X, XI and XII) and administration of heparin are the main elements
responsible for increased PATT. In the current study no important changes
or statistically significant alterations were found between the PATT levels
on admission and discharge, which allows for the supposition that
intrinsic coagulation factors are not significantly altered in human
leptospirosis, thus remaining uninvolved in the genesis of hemorrhagic
disturbances.
Fibrinogen is produced by the liver and by cells within the endothelial
reticulum system. The plasmatic concentration of fibrinogen may increase
up to 2.5 times after inflammatory stimuli and can remain elevated during
several weeks. In the present study a significant increase in fibrinogen
was seen, which can be considered a consequence of the inflammatory
reaction that occurs in leptospirosis. HIGGINS & COUSINEAU12
interpreted the resulting fibrinogen elevation and hemorrhagic
disturbances in guinea pigs infected with leptospirosis as being a result
of the increased fibrinogen production by the liver in response to increased
consumption. On the other hand, SITPRIJA et al.29 attributed this increase
to the phenomenon of vascular endothelial lesions caused by the
leptospira.
In our study, platelet counts were found to be significantly lower
upon admission than at time of discharge, with the admission levels of
platelets reduced to values that were much lower than normal, at levels
compatible with the appearance of hemorrhagic manifestations. This
seems to be the part of coagulation most affected in the severe forms of
leptospirosis. Such findings are in accordance with those observed by
several authors7,15,19-23. NICODEMO et al.22 observed that
thrombocytopenia in leptospirosis seems to be determined by activation,
adhesion and aggregation of platelets to the stimulated vascular
endothelium by the action of endotoxin or other bacterial products.
Adhesion may be mediated by platelets surface receptors that have a
high affinity for adhesion glycoproteins detected in the subendothelium.
The same authors identified in vascular lung fragments of the patients
with severe leptospirosis a formation of an amorphous electron-dense
substance, between the endothelial cells and adherent platelets, that could
be von Willenbrand factor or other endothelium adhesion protein. This
would lead subsequent adhesion of platelets in those places where the
subendothelial collagen was not exposed and the presence of fibrin in
the platelets aggregates was not observed.
Disseminated intravascular coagulation is an epiphenomenon that
involves the following laboratory alterations: reduced platelet counts;
prolonged TT, PT, and PATT; and normal or reduced fibrinogen. Only
PT prolongation and thrombocytopenia were seen in the present study.
From this information, it can be seen that disseminated intravascular
coagulation does not habitually occur in human leptospirosis. This finding
corroborate with literature data15,21,22.
Nineteen of the 30 patients, in this study, required dialytic treatment
during hospital stay, thus revealing the elevated percentage of severe
leptospirosis with acute renal failure unresponsive to clinical treatment
with hydration and diuretic use. The dialytic indication was due to uremia
and/or volume overload.
In the current study, it was seen that serum urea was highly elevated
in patients with severe leptospirosis and hemorrhages, indicating that
uremia might contribute to the severity of the bleeding disturbances in
leptospirosis. Uremic bleeding appears to correlate most closely with
prolongation of bleeding time, due primarily to platelet dysfunction6,9.
 Regarding analysis for ACL in the sera of the patients studied, the
majority was found to be positive for IgM and IgG with considerably
elevated titers ( 50mpl/gpl) for such antibodies, thus corroborating their
involvement in the severe manifestations of leptospirosis. ACL dosage
in our control group did not display reactive levels of IgG, and IgM was
present in low titers. Statistically significant difference was observed
between titers of both fractions when compared to those of the patients
with leptospirosis. Thus, it can be seen that there is no significant increase
in the presence of these antibodies in infectious diseases other than
leptospirosis. The nature of the pathological findings in leptospirosis
for vascular lesions (vasculitis) and hemorrhage is probably due to
cytotoxic and immunologic mechanisms28. The presence of ACL in
leptospirosis suggests that these antibodies can induce cross reactivity
with vascular endothelial cells and with other cell membranes,
contributing perhaps to the physiopathologic mechanisms of the severe
form of this disease, among these being the hemorrhagic disturbances28.
Regarding mortality, in our study, was observed that in all of the
cases bleeding was implicated as a possible cause. This is in agreement
with the data in the scientific literature which describe bleeding as the
main cause of death in leptospirosis10,16,25.
In conclusion, the hemorrhagic manifestations occurred after one
week following symptoms onset. The coagulation disorders revealed no
disseminated intravascular coagulation in the severe leptospirosis.
Thrombocytopenia in the acute phase of the illness plays a role in the
hemorrhagic disturbances. ACL assay showed that the majority of patients
had reactive titers for the IgM and IgG fractions in the severe form of
leptospirosis. Uremia is a factor that also contributes to bleeding in the
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acute phase of disease. The hemorrhagic disturbances represent the main
cause of death.
RESUMO
Avaliação das alterações da hemostasia e anticorpo
anticardiolipina em pacientes com a forma grave da leptospirose
Foram avaliados prospectivamente os fatores envolvidos nas alterações
da hemostasia e níveis de anticorpo anticardiolipina em 30 pacientes com
a forma grave da leptospirose e insuficiência renal aguda (IRA) (IRA foi
definida como creatinina sérica > 1,5 mg/dl). Os pacientes foram internados
no Hospital Universitário Walter Cantídio, Hospital São José de Doenças
Infecciosas e Hospital Geral de Fortaleza, Ceará, de agosto/1999 a julho/
2001. Todos eram do sexo masculino com idade de 32 ± 14 anos e
apresentavam manifestações clínicas com diagnóstico laboratorial de
leptospirose associada à IRA. O tempo do início dos sintomas ao
aparecimento das manifestações hemorrágicas foi de 9 ± 4 dias. As
manifestações hemorrágicas foram observadas em 86% dos pacientes.
Dados laboratoriais mostraram níveis significativamente elevados de uréia,
181 ± 95 mg/dl; fibrinogênio, 515 ± 220 mg/dl; tempo ativado de
protrombina, 13,3 ± 0,9 seg e diminuição das plaquetas, 69 ± 65x103/mm3
na admissão. Não houve alteração no tempo de trombina e de
tromboplastina parcial ativado. Os níveis de ACL IgG e IgM estavam
significativamente elevados (p < 0,05) na forma grave da leptospirose
quando comparados ao grupo controle (28,5 ± 32,4 vs. 11,5 ± 7,9MPL U/
ml e 36,7 ± 36,1 vs. 6,5 ± 2,5 GPL U/ml), respectivamente. A vasculite,
trombocitopenia e uremia devem ser consideradas como fatores importantes
na patogênese dos distúrbios hemorrágicos observados na forma grave da
leptospirose que constituem a principal causa de óbito na doença.
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